MDM2 and ovarian carcinoma: Incidence and age of onset of all malignancies, breast and ovarian cancer in carriers of pathogenic BRCA1 mutations genotyped for MDM2 SNP309 (p values refer to comparisons of frequencies between the G/G, G/T and T/T subgroups)